MedPath

Growth Hormone (GH) Replacement Therapy Decreased Plasma Diacron-reactive Oxygen Metabolites levels and subsequently, improved Endothelial Function as Assessed by Peripheral Arterial Tonometry in Japanese Patient with growth Hormone deficiency

Not Applicable
Conditions
Growth Hormone Deficiency
Registration Number
JPRN-UMIN000025223
Lead Sponsor
Dokkyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1.type 1 or 2 diabetes, 2.severe liver dysfunction 3.severe infections 4.pregnant or nursing women and those who might be pregnant 5.malignancy or the history of malignancy 6.alcoholism 7 any patients whom the investigators judged to be inappropriate for this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath